Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression

被引:102
作者
Chen, Bin [1 ]
Zhang, Youzhi [2 ]
Wang, Yang [1 ]
Rao, Jun [1 ]
Jiang, Xiaomei [1 ]
Xu, Zihui [2 ]
机构
[1] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing 400038, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Dept Integrat Med, Chongqing 400037, Peoples R China
基金
中国国家自然科学基金;
关键词
Curcumin; Breast cancer; Nrf2; Fen1; MCF-7; CELLS; CONSENSUS SEQUENCE; GENE-EXPRESSION; CYCLIN D1; IN-VIVO; IDENTIFICATION; TRANSCRIPTION; REPRESSION; MUTATIONS; APOPTOSIS;
D O I
10.1016/j.jsbmb.2014.01.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Curcumin can inhibit cell proliferation of breast cancer, but the mechanism for this inhibition remains unclear. Over-expression of Flap endonuclease 1 (Fen1), a DNA repair-specific nuclease, is involved in the development of breast cancer. Nrf2 is a master regulator of cellular antioxidant defense systems. Curcumin can induce the expression of Nrf2 in both non-breast cancer cells and breast cancer cells. However, whether curcumin-induced inhibition of breast cancer cell proliferation may involve Nrf2-mediated Fen1 expression is not yet understood. In this study, we demonstrated that curcumin inhibited Fen1 -dependent proliferation of MCF-7 cells and significantly induced Nrf2 protein expression while inhibiting Fen1 protein expression. Curcumin could down-regulate Fen1 gene expression in a Nrf2-dependent manner. Further investigation revealed that curcumin could lead to Nrf2 translocation from the cytoplasm to the nucleus and decrease Fen1 promoter activity by decreasing the recruitment of Nrf2 to the Fen1 promoter. These data suggest that curcumin may inhibit the proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression, which may be a new mechanism of curcumin-induced tumor growth inhibition. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 32 条
[1]   Curcumin and cancer: An "old-age" disease with an "age-old" solution [J].
Anand, Preetha ;
Sundaram, Chitra ;
Jhurani, Sonia ;
Kunnumakkara, Ajaikumar B. ;
Aggarwal, Bharat B. .
CANCER LETTERS, 2008, 267 (01) :133-164
[2]   Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer [J].
Byrns, Michael C. ;
Duan, Ling ;
Lee, Seon Hwa ;
Blair, Ian A. ;
Penning, Trevor M. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 118 (03) :177-187
[3]   Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptin-resistant breast cancer cells [J].
Chen, Bin ;
Wang, Yuanzhong ;
Kane, Susan E. ;
Chen, Shiuan .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2008, 41 (5-6) :367-377
[4]   Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis [J].
De Nicola, Gina M. ;
Karreth, Florian A. ;
Humpton, Timothy J. ;
Gopinathan, Aarthi ;
Wei, Cong ;
Frese, Kristopher ;
Mangal, Dipti ;
Yu, Kenneth H. ;
Yeo, Charles J. ;
Calhoun, Eric S. ;
Scrimieri, Francesca ;
Winter, Jordan M. ;
Hruban, Ralph H. ;
Iacobuzio-Donahue, Christine ;
Kern, Scott E. ;
Blair, Ian A. ;
Tuveson, David A. .
NATURE, 2011, 475 (7354) :106-U128
[5]   Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression [J].
Dickinson, DA ;
Iles, KE ;
Zhang, HQ ;
Blank, V ;
Forman, HJ .
FASEB JOURNAL, 2003, 17 (01) :473-+
[6]   The peroxisome proliferator-activated receptors: Ligands and activators [J].
Forman, BM ;
Chen, J ;
Evans, RM .
PEROXISOMES: BIOLOGY AND ROLE IN TOXICOLOGY AND DISEASE, 1996, 804 :266-275
[7]   THE CHARACTERIZATION OF A MAMMALIAN DNA STRUCTURE-SPECIFIC ENDONUCLEASE [J].
HARRINGTON, JJ ;
LIEBER, MR .
EMBO JOURNAL, 1994, 13 (05) :1235-1246
[8]   Tolerated wobble mutations in siRNAs decrease specificity, but can enhance activity in vivo [J].
Holen, T ;
Moe, SE ;
Sorbo, JG ;
Meza, TJ ;
Ottersen, OP ;
Klungland, A .
NUCLEIC ACIDS RESEARCH, 2005, 33 (15) :4704-4710
[9]  
Hong RL, 1999, CLIN CANCER RES, V5, P1884
[10]   Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies [J].
Hu, Liangao ;
Miao, Weimin ;
Loignon, Martin ;
Kandouz, Mustapha ;
Batist, Gerald .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) :467-474